ChemFeeds Site Navigation:
Journal Selection:
Search:

1) STK11-Driven Regulation of PDE4D (Molecular Cancer Therapeutics) Thursday October 2nd 2014


2) Zebrafish Antilymphatic Drug Screen (Molecular Cancer Therapeutics) Thursday October 2nd 2014


3) Integrin Deregulation by the Anticancer Gallium Compound KP46 (Molecular Cancer Therapeutics) Thursday October 2nd 2014


4) Regulation of NF-{kappa}B Activation by Piperlongumine (Molecular Cancer Therapeutics) Thursday October 2nd 2014


5) BRCA2 and Gemcitabine (Molecular Cancer Therapeutics) Thursday October 2nd 2014


6) P-Glycoprotein Mediated Resistance to Temozolomide in GBM (Molecular Cancer Therapeutics) Thursday October 2nd 2014


7) OSU-03012 and ER Stress (Molecular Cancer Therapeutics) Thursday October 2nd 2014


8) PTTG1 and Response to Paclitaxel Treatment (Molecular Cancer Therapeutics) Thursday October 2nd 2014


9) Lipid Catabolism Blockade Effects in Prostate Cancer (Molecular Cancer Therapeutics) Thursday October 2nd 2014


10) miR34-Based Cancer Therapy Candidate (Molecular Cancer Therapeutics) Thursday October 2nd 2014


11) IFN{alpha} Enhances T-Cell Killing of Solid Cancers (Molecular Cancer Therapeutics) Thursday October 2nd 2014


12) Targeting Melanoma with Nanolipolee-007 (Molecular Cancer Therapeutics) Thursday October 2nd 2014


13) BET Antagonist and FLT3-TKI against AML Cells (Molecular Cancer Therapeutics) Thursday October 2nd 2014


14) ICG-001 Inhibits Pancreatic Cancer Growth (Molecular Cancer Therapeutics) Thursday October 2nd 2014


15) Simvastatin and Metformin Combination Chemotherapy (Molecular Cancer Therapeutics) Thursday October 2nd 2014


16) Fludarabine Phosphate Repurposed for GIST (Molecular Cancer Therapeutics) Thursday October 2nd 2014


17) Targeting Endoglin in Pancreatic Cancer (Molecular Cancer Therapeutics) Thursday October 2nd 2014


18) Target Vemurafenib Resistance by the CDK4/6 Inhibitor LY2835219 (Molecular Cancer Therapeutics) Thursday October 2nd 2014


19) Correction: The Phosphoinositide 3-Kinase {alpha} Selective Inhibitor BYL719 Enhances the Effect of the Protein Kinase C Inhibitor AEB071 in GNAQ/GNA11-Mutant Uveal Melanoma Cells (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


20) Correction: Driven to Death: Inhibition of Farnesylation Increases Ras Activity in Osteosarcoma and Promotes Growth Arrest and Cell Death (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


21) Correction: Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-{kappa}B Activation, and Is Active in Patient-Derived Xenograft Models (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


22) Predictive Value of EGFL7 in mCRC (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


23) Pharmacogenetic Predictors in Early-Stage Colon Cancer (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


24) Biomarker for CBP501 (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


25) Combination of Quinacrine and Erlotinib in NSCLC (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


26) Novel Human Fusion Protein Kills EpCAM-Positive Cancer Cells (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


27) CDK4/6 Inhibitor Reduces Human Liposarcoma Growth (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


28) Dose Schedule Optimization with Combined MLN8237 and Taxanes (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


29) Cyclopamine Glucuronide Prodrug toward Glioma Stem Cells (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


30) NIR Fluorescent Choline Kinase Inhibitor (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


31) Axl Kinase as an Emerging Key Target for Drug Discovery (Molecular Cancer Therapeutics) Wednesday September 3rd 2014


32) IL15-Secreting MSCs Exert Antitumor Potential (Molecular Cancer Therapeutics) Tuesday August 5th 2014


33) TDP1 and TDP2 Inhibitor Screening (Molecular Cancer Therapeutics) Tuesday August 5th 2014


34) CENP-E Motor Function in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Tuesday August 5th 2014


35) Mechanism of Action of the Novel Taxane Cabazitaxel (Molecular Cancer Therapeutics) Tuesday August 5th 2014


36) TGF-Stimulated Mesothelial Cells in Ovarian Cancer Progression (Molecular Cancer Therapeutics) Tuesday August 5th 2014


37) DDX43 Induces RAS Signaling and Drug Resistance (Molecular Cancer Therapeutics) Tuesday August 5th 2014


38) PP2A Inhibitor Sensitizes HCC to Chemotherapy (Molecular Cancer Therapeutics) Tuesday August 5th 2014


39) FAK Controls Ovarian Carcinoma Spheroid Growth (Molecular Cancer Therapeutics) Tuesday August 5th 2014


40) Activity of RG7787 in Pancreatic Cancer Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


41) Bispecific HER2-Targeting FynomAb with Superior Activity (Molecular Cancer Therapeutics) Tuesday August 5th 2014


42) s50-TBG-RNAi-CK2 Targets Primary and Metastatic HNSCC (Molecular Cancer Therapeutics) Tuesday August 5th 2014


43) Novel Drug for Treatment of Temozolomide-Resistant Gliomas (Molecular Cancer Therapeutics) Tuesday August 5th 2014


44) AKI603 Attenuates Breast Tumor Initiating Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


45) AR-42 Targets AML Stem Cells (Molecular Cancer Therapeutics) Tuesday August 5th 2014


46) A Pragmatic Definition of Therapeutic Synergy (Molecular Cancer Therapeutics) Monday July 7th 2014


47) miR-3607 in Prostate Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


48) miR26b Regulates Cancer Proliferation (Molecular Cancer Therapeutics) Monday July 7th 2014


49) Repositioning Drugs for Renal Cell Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


50) Mutation Profile of Melanomas Lacking Known Driver Mutations (Molecular Cancer Therapeutics) Monday July 7th 2014


51) BET Bromodomain Inhibition and Pancreatic Cancer Progression (Molecular Cancer Therapeutics) Monday July 7th 2014


52) Antiproliferative Synergism of CK2 and BRAF Inhibitors (Molecular Cancer Therapeutics) Monday July 7th 2014


53) Targeting ER{beta} in SERM-Resistant Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


54) LXR Inhibition of Myeloma Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


55) SIRT1 in the Antitumor Activity of Silybin (Molecular Cancer Therapeutics) Monday July 7th 2014


56) ABT-737 Enhances MEK/mTOR Inhibition-Induced AML Apoptosis (Molecular Cancer Therapeutics) Monday July 7th 2014


57) PIK3R3 Induces EMT, Promoting Metastasis of Colorectal Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


58) MM-121 Combined with Cetuximab in HNSCC Preclinical Models (Molecular Cancer Therapeutics) Monday July 7th 2014


59) Prostate Cancer-Targeted Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


60) Pretargeted RIT of GD2 with an Anti-GD2/DOTA IgG-scFv (Molecular Cancer Therapeutics) Monday July 7th 2014


61) Anti-sEcad mAb-Induced Suppression of Skin SCCs (Molecular Cancer Therapeutics) Monday July 7th 2014


62) Generation of a Canine Anti-EGFR Antibody (Molecular Cancer Therapeutics) Monday July 7th 2014


63) Antibody-Based Delivery of IL2 and Cytotoxics (Molecular Cancer Therapeutics) Monday July 7th 2014


64) Targeting Pancreatic Cancer Stem Cells (Molecular Cancer Therapeutics) Monday July 7th 2014


65) Effect of Metronomic Docetaxel in PRINT Particles and siEZH2 (Molecular Cancer Therapeutics) Monday July 7th 2014


66) Redox-Active Cerium Oxide Nanoparticles in Cancer Therapy (Molecular Cancer Therapeutics) Monday July 7th 2014


67) Anti-miR182 Treatment in Ovarian Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


68) GGA Exerts Cardioprotective and Anticancer Effects (Molecular Cancer Therapeutics) Monday July 7th 2014


69) EW-7197, an Antimetastatic Drug in Breast Cancer (Molecular Cancer Therapeutics) Monday July 7th 2014


70) Leelamine Inhibits Intracellular Cholesterol Transport (Molecular Cancer Therapeutics) Monday July 7th 2014


71) Targeting Melanomas Using Leelamine (Molecular Cancer Therapeutics) Monday July 7th 2014


72) Correction: Characterisation of the Novel Apoptotic and Therapeutic Activities of the Histone Deacetylase Inhibitor Romidepsin (Molecular Cancer Therapeutics) Thursday June 5th 2014


73) Efficacy of Zibotentan in Colorectal Cancer--Response (Molecular Cancer Therapeutics) Thursday June 5th 2014


74) Efficacy of Zibotentan in Colorectal Cancer--Letter (Molecular Cancer Therapeutics) Thursday June 5th 2014


75) 3D Environment in Chemoresistance of GBM Stem-like Cells (Molecular Cancer Therapeutics) Thursday June 5th 2014


76) ABT-737 Mediates Dislocation of ER Luminal Proteins (Molecular Cancer Therapeutics) Thursday June 5th 2014


77) PARP Inhibitors' Off-Target Effects (Molecular Cancer Therapeutics) Thursday June 5th 2014


78) Aflibercept versus Bevacizumab in PDX Colorectal Cancer Tumors (Molecular Cancer Therapeutics) Thursday June 5th 2014


79) MLN4924 DNA-Damaging Agent Combinations (Molecular Cancer Therapeutics) Thursday June 5th 2014


80) KRAS Status Predicts Antifolate Sensitivity (Molecular Cancer Therapeutics) Thursday June 5th 2014


81) Antibody-Drug Con{#x0237}ugate BRAF Inhibitor Combination (Molecular Cancer Therapeutics) Thursday June 5th 2014


82) Akt/Autophagy for Sorafenib Resistance in HCC (Molecular Cancer Therapeutics) Thursday June 5th 2014


83) Significance of the PELP1-mTOR Axis in Endocrine Resistance (Molecular Cancer Therapeutics) Thursday June 5th 2014


84) BAFF-R as Target for Antibody Therapy in ALL (Molecular Cancer Therapeutics) Thursday June 5th 2014


85) Noncytotoxic Treatment of Micrometastases (Molecular Cancer Therapeutics) Thursday June 5th 2014


86) AMG 330, a Novel CD3/CD33 BiTE Antibody (Molecular Cancer Therapeutics) Thursday June 5th 2014


87) Mesothelin-Targeting Antibody-Drug Con{#x0237}ugate (Molecular Cancer Therapeutics) Thursday June 5th 2014


88) Alternol Induces ROS-Dependent Apoptosis (Molecular Cancer Therapeutics) Thursday June 5th 2014


89) Tumor Targeting with Integrin {alpha}v{beta}3 and MMP-2 (Molecular Cancer Therapeutics) Thursday June 5th 2014


90) Immunotherapy for Hepatoma Using a Dual-Function Vector (Molecular Cancer Therapeutics) Thursday June 5th 2014


91) Small Molecule Inhibits ETV1 Acetylation and Function (Molecular Cancer Therapeutics) Thursday June 5th 2014


92) The JNK-MCL-1 Axis Contributes to the Anticancer Activity of MT189 (Molecular Cancer Therapeutics) Thursday June 5th 2014


93) Covalent EGFR Mutant-Selective Inhibitors (Molecular Cancer Therapeutics) Thursday June 5th 2014


94) A Small Molecule Inhibitor of EMT Pathways (Molecular Cancer Therapeutics) Thursday June 5th 2014


95) LY2857785 Is a CDK9 Inhibitor with Preclinical Antitumor Activity (Molecular Cancer Therapeutics) Thursday June 5th 2014


96) Coleusin Factor Restores Differentiation of Osteosarcoma (Molecular Cancer Therapeutics) Thursday June 5th 2014


97) Hec1 Inhibitor against Breast Cancer (Molecular Cancer Therapeutics) Thursday June 5th 2014


98) Inhibitors of Lactate Influx but Not Efflux (Molecular Cancer Therapeutics) Thursday June 5th 2014


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

Formal Total Synthesis of (–)-Taxol

Compound Reverses The Anticlotting Effects Of Heparin

Oil Rose And Then Fell After Deepwater Horizon Disaster


Lab Death Legal Defense Cost University Of California Nearly $4.5 Million

Reactive Lewis Pairs Hydrogenate Carbonyls

Sasol Moves Ahead On Louisiana Ethylene

Big Chemical Firms See Strong Third Quarter


Nivolumab Racks Up Another Success

CSB releases recommendations on classroom methanol-related demonstrations

The 100 most highly cited papers of all time: Tools, not ideas

Three Pipette Horror Stories in the Lab

Tailoring An Electrolyte For High-Efficiency Lithium-Air Batteries

Williamson Ether Synthesis: Planning

Down With the Western Blot?

Threading Polymers Through a Macrocyclic Ring


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()